Immunostimulation before chemotherapy in cancer treatment.
作者信息
Frati L, Barzi A, Caprino M C, Menconi E, Bonmassar E
出版信息
Pharmacol Res Commun. 1977 Sep;9(8):689-99. doi: 10.1016/s0031-6989(77)80060-x.
PMID:563086
Abstract
摘要
相似文献
1
Immunostimulation before chemotherapy in cancer treatment.
Pharmacol Res Commun. 1977 Sep;9(8):689-99. doi: 10.1016/s0031-6989(77)80060-x.
2
Immunotherapy of cancer: current status.
Prog Exp Tumor Res. 1980;25:61-88. doi: 10.1159/000403177.
3
Biologic response modifiers as adjuncts to other therapeutic modalities.
Semin Oncol. 1986 Jun;13(2):144-52.
4
Immunotherapy from malignant disease.
Annu Rev Med. 1978;29:231-83. doi: 10.1146/annurev.me.29.020178.001311.
5
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Ann N Y Acad Sci. 1976;277(00):135-59. doi: 10.1111/j.1749-6632.1976.tb41695.x.
6
BCG as adjuvant immunotherapy for neoplasia.
Annu Rev Med. 1977;28:489-515. doi: 10.1146/annurev.me.28.020177.002421.
7
Changes in the patterns of patient therapy and multidisciplinary consultation in CHOP and in comparison hospitals.
Prog Clin Biol Res. 1986;216:91-104.
8
[Cancer therapy--difficulties in treatment].
Duodecim. 1967;83(22):1275-9.
9
The impact of the Community Hospital Oncology Program (CHOP) on the quality of data reporting.
Prog Clin Biol Res. 1986;216:131-41.
10
Assessing the economic value of anticancer therapies.
Recent Results Cancer Res. 1998;148:1-285. doi: 10.1007/978-3-642-72123-6.
Zotero 插件